BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12643447)

  • 1. Cytochemical demonstration of expression and distribution of non-glycosylated human lysosomal cathepsin S in HEK 293 cells.
    Nissler K; Oehring H; Krieg R; Pierskalla A; Weber E; Wiederanders B; Halbhuber KJ
    Cell Mol Biol (Noisy-le-grand); 2002; 48 Online Pub():OL297-308. PubMed ID: 12643447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorting of non-glycosylated human procathepsin S in mammalian cells.
    Nissler K; Kreusch S; Rommerskirch W; Strubel W; Weber E; Wiederanders B
    Biol Chem; 1998 Feb; 379(2):219-24. PubMed ID: 9524075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293.
    Cappiello MG; Wu Z; Scott BB; McGeehan GM; Harrison RK
    Protein Expr Purif; 2004 Sep; 37(1):53-60. PubMed ID: 15294281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse procathepsin L lacking a functional glycosylation site is properly folded, stable, and secreted by NIH 3T3 cells.
    Kane SE
    J Biol Chem; 1993 May; 268(15):11456-62. PubMed ID: 8496193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of carboxy-terminal amino acids in secretion of human lysosomal protease cathepsin L.
    Chauhan SS; Ray D; Kane SE; Willingham MC; Gottesman MM
    Biochemistry; 1998 Jun; 37(23):8584-94. PubMed ID: 9622510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans.
    Vasiljeva O; Dolinar M; Pungercar JR; Turk V; Turk B
    FEBS Lett; 2005 Feb; 579(5):1285-90. PubMed ID: 15710427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evolutionarily conserved tripartite tryptophan motif stabilizes the prodomains of cathepsin L-like cysteine proteases.
    Kreusch S; Fehn M; Maubach G; Nissler K; Rommerskirch W; Schilling K; Weber E; Wenz I; Wiederanders B
    Eur J Biochem; 2000 May; 267(10):2965-72. PubMed ID: 10806395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The propeptide of cruzipain--a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F.
    Reis FC; Costa TF; Sulea T; Mezzetti A; Scharfstein J; Brömme D; Ménard R; Lima AP
    FEBS J; 2007 Mar; 274(5):1224-34. PubMed ID: 17298440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the C-terminal end of cathepsin K affect proenzyme secretion and intracellular maturation.
    Claveau D; Riendeau D
    Biochem Biophys Res Commun; 2001 Feb; 281(2):551-7. PubMed ID: 11181082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carbohydrate position on lysosomal transport of procathepsin L.
    Lingeman RG; Joy DS; Sherman MA; Kane SE
    Mol Biol Cell; 1998 May; 9(5):1135-47. PubMed ID: 9571245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foldase function of the cathepsin S proregion is strictly based upon its domain structure.
    Pietschmann S; Fehn M; Kaulmann G; Wenz I; Wiederanders B; Schilling K
    Biol Chem; 2002 Sep; 383(9):1453-8. PubMed ID: 12437139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observing proteases in living cells.
    Moin K; Demchik L; Mai J; Duessing J; Peters C; Sloane BF
    Adv Exp Med Biol; 2000; 477():391-401. PubMed ID: 10849765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing and transport of the precursor of cathepsin C during its transfer into lysosomes.
    Muno D; Ishidoh K; Ueno T; Kominami E
    Arch Biochem Biophys; 1993 Oct; 306(1):103-10. PubMed ID: 8215389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells.
    Nielsen R; Courtoy PJ; Jacobsen C; Dom G; Lima WR; Jadot M; Willnow TE; Devuyst O; Christensen EI
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5407-12. PubMed ID: 17369355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The half-life of human procathepsin S.
    Nissler K; Strubel W; Kreusch S; Rommerskirch W; Weber E; Wiederanders B
    Eur J Biochem; 1999 Aug; 263(3):717-25. PubMed ID: 10469135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autographa californica M nucleopolyhedrovirus ProV-CATH is activated during infected cell death.
    Hom LG; Ohkawa T; Trudeau D; Volkman LE
    Virology; 2002 May; 296(2):212-8. PubMed ID: 12069520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of in vitro folding conditions for procathepsin S and cathepsin S using fractional factorial screens.
    Tobbell DA; Middleton BJ; Raines S; Needham MR; Taylor IW; Beveridge JY; Abbott WM
    Protein Expr Purif; 2002 Mar; 24(2):242-54. PubMed ID: 11858719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of the cathepsin F-like cysteine protease gene in Escherichia coli and its characterization.
    Joo HS; Koo KB; Park KI; Bae SH; Yun JW; Chang CS; Choi JW
    J Microbiol; 2007 Apr; 45(2):158-67. PubMed ID: 17483802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of differential processing of procathepsin H on its aminopeptidase activity, secretion and subcellular localization in human cell lines.
    Rojnik M; Jevnikar ZR; Doljak B; Turk S; Zidar N; Kos J
    Eur J Cell Biol; 2012 Oct; 91(10):757-64. PubMed ID: 22704610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternate targeting pathway for procathepsin L in mouse fibroblasts.
    Ahn K; Yeyeodu S; Collette J; Madden V; Arthur J; Li L; Erickson AH
    Traffic; 2002 Feb; 3(2):147-59. PubMed ID: 11929604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.